Myokine function of MG53 in muscle injury-repair and regeneration

MG53在肌肉损伤修复和再生中的肌因子功能

基本信息

  • 批准号:
    10268967
  • 负责人:
  • 金额:
    $ 34.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-04-15 至 2023-03-31
  • 项目状态:
    已结题

项目摘要

SUMMARY Skeletal muscle injury-repair and regeneration is a multi-cellular process that involves repair of acute injury to the sarcolemma, mobilization of satellite cells to replace the lost-muscle fibers, and control of fibrotic remodeling for maintenance of muscle integrity. In muscular dystrophy, compromised sarcolemma integrity or membrane repair triggers the cascade of muscle degeneration that incurs progressive, severe morbidity and ultimately mortality. Developing therapeutic approaches to improve sarcolemma integrity while facilitating regeneration of injured muscle fibers remain a major challenge in muscle physiology research. This project builds on the discovery of MG53, a member of the TRIM-family protein, as an essential component of the cell membrane repair machinery. MG53 functions in vesicle trafficking and facilitates the nucleation of intracellular vesicles to sites of membrane disruption for repair patch formation. Native MG53 is present in blood circulation, at levels directly correlating with injury or secretory activity of the muscle. Administration of recombinant human MG53 (rhMG53) protein protects muscle fibers and stem cells from injury, and reduces muscle fibrosis in the mdx mouse model. Our research with MG53 over the past few years has established a potential tri-functional role for MG53 in muscle injury-regeneration, as a facilitator to repair acute sarcolemma injury, a contributor to activate satellite cells during the early phase of muscle injury, and a modulator of fibrosis by controlling fibroblast differentiation associated with chronic muscle injury. We envision that targeting the tri-functional role of MG53 will have advantage over the current paradigms for treating muscular dystrophy. In Aim 1, we will determine the pathways that transduce the newly identified myokine function of MG53 into activation of satellite cells in response to acute muscle injury; define the mechanisms that underlie MG53’s function in regulating fibrosis during chronic muscle injury; and test if non-invasive interventions can modulate circulating MG53 levels toward muscle injury-regeneration. If circulating MG53 plays a role in satellite cell activation, we predict that ischemia-preconditioning that releases MG53 without muscle injury, or inducible secretion of MG53 from a transgenic mouse model, will effectively activate satellite cells and muscle regeneration following injury. In Aim 2, we will evaluate the safety and efficacy for sustained elevation of MG53 in circulation to preserve muscle integrity/satellite cell activation/fibrosis control in animal models of muscular dystrophy. Fulfillment of the studies in this project will advance the biology of MG53 in muscle injury-repair and regeneration, and lay the foundation for our translational approach for targeting MG53 function for treatment of muscular dystrophy.
摘要 骨骼肌损伤-修复和再生是一个多细胞过程,涉及急性损伤的修复 肌膜,动员卫星细胞以替代丢失的肌肉纤维,以及控制纤维化 重塑以保持肌肉的完整性。在肌营养不良症中,肌膜完整性或 膜修复触发肌肉退行性变的级联反应,导致进行性、严重的发病率和 最终是死亡。开发治疗方法以改善肌膜完整性,同时促进 损伤肌肉纤维的再生仍然是肌肉生理学研究中的一大挑战。这个项目 建立在发现MG53的基础上,MG53是TRIM家族蛋白的成员,是细胞的重要组成部分 膜修补机械。MG53在囊泡运输中的作用并促进细胞内的成核 小泡到膜破裂的部位以修复补丁的形成。天然的MG53存在于血液循环中, 与肌肉损伤或分泌活动直接相关的水平。重组人的给药 MG53(RhMG53)蛋白保护肌肉纤维和干细胞免受损伤,并减少肌肉纤维化 MDX小鼠模型。我们在过去几年对MG53的研究已经建立了一个潜在的三功能 MG53在肌肉损伤-再生中的作用,作为修复急性肌膜损伤的促进器,贡献于 在肌肉损伤的早期阶段激活卫星细胞,并通过控制 成纤维细胞分化与慢性肌肉损伤相关。我们设想,以三大职能角色为目标 与目前治疗肌营养不良症的范例相比,MG53的治疗方案将具有优势。在目标1中,我们将 确定将新发现的MG53肌动因子功能转化为卫星激活的途径 细胞对急性肌肉损伤的反应;确定MG53的S调节功能的机制 慢性肌肉损伤时的纤维化;以及测试非侵入性干预是否可以调节循环MG53 肌肉损伤-再生的水平。如果循环中的MG53在卫星细胞激活中起作用,我们预测 在不损伤肌肉的情况下释放MG53的缺血预适应,或从 转基因小鼠模型,将有效激活损伤后的卫星细胞和肌肉再生。在AIM 2、我们将评估持续升高循环中MG53以保存肌肉的安全性和有效性 肌营养不良动物模型的完整性/卫星细胞激活/纤维化控制。履行 本项目的研究将促进MG53在肌肉损伤修复和再生方面的生物学研究,并为 为我们针对MG53功能治疗肌营养不良症的翻译方法奠定基础。

项目成果

期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer.
  • DOI:
    10.1186/s12943-021-01418-3
  • 发表时间:
    2021-09-14
  • 期刊:
  • 影响因子:
    37.3
  • 作者:
    Li H;Lin PH;Gupta P;Li X;Zhao SL;Zhou X;Li Z;Wei S;Xu L;Han R;Lu J;Tan T;Yang DH;Chen ZS;Pawlik TM;Merritt RE;Ma J
  • 通讯作者:
    Ma J
BVES is a novel interactor of ANO5 and regulates myoblast differentiation.
BVES 是 ANO5 的一种新型相互作用因子,可调节成肌细胞分化。
  • DOI:
    10.1186/s13578-021-00735-w
  • 发表时间:
    2021-12-28
  • 期刊:
  • 影响因子:
    7.5
  • 作者:
    Li H;Xu L;Gao Y;Zuo Y;Yang Z;Zhao L;Chen Z;Guo S;Han R
  • 通讯作者:
    Han R
Cardiac differentiation of cardiosphere-derived cells in scaffolds mimicking morphology of the cardiac extracellular matrix.
  • DOI:
    10.1016/j.actbio.2014.04.018
  • 发表时间:
    2014-08
  • 期刊:
  • 影响因子:
    9.7
  • 作者:
    Xu Y;Patnaik S;Guo X;Li Z;Lo W;Butler R;Claude A;Liu Z;Zhang G;Liao J;Anderson PM;Guan J
  • 通讯作者:
    Guan J
Multi-Cellular Functions of MG53 in Muscle Calcium Signaling and Regeneration.
  • DOI:
    10.3389/fphys.2020.583393
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Benissan-Messan DZ;Zhu H;Zhong W;Tan T;Ma J;Lee PHU
  • 通讯作者:
    Lee PHU
MG53, A Tissue Repair Protein with Broad Applications in Regenerative Medicine.
MG53,一种在再生医学中广泛应用的组织修复蛋白。
  • DOI:
    10.3390/cells10010122
  • 发表时间:
    2021-01-11
  • 期刊:
  • 影响因子:
    6
  • 作者:
    Li Z;Wang L;Yue H;Whitson BA;Haggard E;Xu X;Ma J
  • 通讯作者:
    Ma J
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Renzhi Han其他文献

Renzhi Han的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Renzhi Han', 18)}}的其他基金

Base editing of ASGR1 for cardiovascular disease
ASGR1 碱基编辑治疗心血管疾病
  • 批准号:
    10590146
  • 财政年份:
    2023
  • 资助金额:
    $ 34.21万
  • 项目类别:
Controllable base editing therapy for DMD
DMD 的可控碱基编辑疗法
  • 批准号:
    10728698
  • 财政年份:
    2023
  • 资助金额:
    $ 34.21万
  • 项目类别:
ANO5 in Muscle Health and Disease
ANO5 在肌肉健康和疾病中的作用
  • 批准号:
    10378023
  • 财政年份:
    2019
  • 资助金额:
    $ 34.21万
  • 项目类别:
ANO5 in Muscle Health and Disease
ANO5 在肌肉健康和疾病中的作用
  • 批准号:
    10793789
  • 财政年份:
    2019
  • 资助金额:
    $ 34.21万
  • 项目类别:
Molecular and cellular functions of Ano5 in heart
Ano5在心脏中的分子和细胞功能
  • 批准号:
    8823821
  • 财政年份:
    2015
  • 资助金额:
    $ 34.21万
  • 项目类别:
Molecular and cellular functions of Ano5 in heart
Ano5在心脏中的分子和细胞功能
  • 批准号:
    9035423
  • 财政年份:
    2015
  • 资助金额:
    $ 34.21万
  • 项目类别:
Molecular and cellular functions of Ano5 in heart
Ano5在心脏中的分子和细胞功能
  • 批准号:
    8981124
  • 财政年份:
    2015
  • 资助金额:
    $ 34.21万
  • 项目类别:
Mechanisms of Muscle Inflammation in Muscular Dystrophy
肌营养不良症中肌肉炎症的机制
  • 批准号:
    8847225
  • 财政年份:
    2014
  • 资助金额:
    $ 34.21万
  • 项目类别:
Mechanisms of Muscle Inflammation in Muscular Dystrophy
肌营养不良症中肌肉炎症的机制
  • 批准号:
    9271865
  • 财政年份:
    2014
  • 资助金额:
    $ 34.21万
  • 项目类别:
Molecular and cellular functions of Ano5 in heart
Ano5在心脏中的分子和细胞功能
  • 批准号:
    8690963
  • 财政年份:
    2013
  • 资助金额:
    $ 34.21万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 34.21万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.21万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 34.21万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.21万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 34.21万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 34.21万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.21万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 34.21万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 34.21万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.21万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了